Personalized dose reduction strategies for biologic disease-modifying antirheumatic drugs for treating axial spondyloarthritis: a clinical and economic evaluation with predictive modeling

Related articles

1. Gender differences in clinical and prescribing characteristics of biologic and targeted synthetic drugs in naïve patients with rheumatoid arthritis: Data from BIOBADASER III registry

   This article has 16 authors:

   1. Paloma Vela-Casasempere
   2. Lucía Otero-Varela
   3. Silvia Gómez Sabater
   4. Rocío Caño Alameda
   5. Cristina Campos Fernández
   6. Jerusalén Calvo-Gutiérrez
   7. Yanira Pérez-Vera
   8. Sara Manrique Arija
   9. Sagrario Bustabad
   10. Javier Manero Ruiz
   11. María Dolores Ruiz Montesino
   12. Lucía Ruíz Gutiérrez
   13. Antonio Mera Varela
   14. Manuel José Moreno Ramos
   15. Fernando Sánchez-Alonso
   16. Isabel Castrejón

2. Individualized Management of Osteoarthritis: The Role of Pharmacogenomics to Optimize Pain Therapy

   This article has 2 authors:

   1. Isabella M Sturgeon
   2. Youssef Malak Roman

3. Dupilumab step-down strategy to maintain remission in adult and adolescent patients with atopic dermatitis: study protocol for a non-inferiority randomized trial (MADULO)

   This article has 13 authors:

   1. Aurore FOUREAU¹²³
   2. Elodie FAUREL-PAUL⁴
   3. Jean-Benoît HARDOUIN⁴
   4. Lola PAPINOT¹²
   5. Solène SCHIRR-BONNANS⁴
   6. Philippe TESSIER⁴
   7. Alexandra JOBERT⁴
   8. Alexandra POINAS²
   9. Delphine STAUMONT-SALLE³⁵
   10. Marie TAUBER⁶
   11. Olivier CHOSIDOW³⁷
   12. Sébastien BARBAROT¹²³
   13. Hélène AUBERT¹²